Clinical Trial Results:
A Phase II, Non-randomized, Multicenter Study to Evaluate the Safety and Efficacy of Pazopanib (GW786034) as Pre-Surgical Therapy in Treatment-Naïve Subjects with Stage IA or IB, Resectable Non Small Cell Lung Cancer (NSCLC)
Summary
|
|
EudraCT number |
2006-000143-26 |
Trial protocol |
ES IT |
Global completion date |
07 Apr 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Jul 2016
|
First version publication date |
07 Jul 2016
|
Other versions |
|
Summary report(s) |
105290-FDAAA-Result-Summary |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.